These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31917576)

  • 1. Discovery of Potential Serum Protein Biomarkers in Ankylosing Spondylitis Using Tandem Mass Tag-Based Quantitative Proteomics.
    Liu S; Ji W; Lu J; Tang X; Guo Y; Ji M; Xu T; Gu W; Kong D; Shen Q; Wang D; Lv X; Wang J; Zhu T; Zhu Y; Liu P; Su J; Wang L; Li Y; Gao P; Liu W; Sun L; Yin X; Zhou W
    J Proteome Res; 2020 Feb; 19(2):864-872. PubMed ID: 31917576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis.
    Liu S; Guo Y; Lu L; Lu J; Ke M; Xu T; Lu Y; Chen W; Wang J; Kong D; Shen Q; Zhu Y; Tan W; Ji W; Zhou W
    Front Immunol; 2020; 11():579228. PubMed ID: 33123164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.
    Fischer R; Trudgian DC; Wright C; Thomas G; Bradbury LA; Brown MA; Bowness P; Kessler BM
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.013904. PubMed ID: 21997733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
    Tsang HHL; Chung HY
    J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis.
    Hwang M; Assassi S; Zheng J; Castillo J; Chavez R; Vanarsa K; Mohan C; Reveille J
    Arthritis Res Ther; 2023 Apr; 25(1):57. PubMed ID: 37041650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between sclerostin level and radiographic changes in patients with ankylosing spondylitis].
    Xie J; Yu X
    Zhonghua Yi Xue Za Zhi; 2015 May; 95(17):1300-4. PubMed ID: 26081658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of serum-derived extracellular vesicles in ankylosing spondylitis patients.
    Huang Y; Feng F; Huang Q; Zheng S; Huang Z; Deng W; Pan X; Li T
    Int Immunopharmacol; 2020 Oct; 87():106773. PubMed ID: 32679547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaphorin 3A in Ankylosing Spondylitis.
    Liao HT; Lin YF; Chou CT; Tsai CY
    J Microbiol Immunol Infect; 2019 Feb; 52(1):151-157. PubMed ID: 28736223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of fatty acid oxidation in the ligament as a contributing factor of ankylosing spondylitis: A comparative proteomic study.
    Xu WD; Yang XY; Li DH; Zheng KD; Qiu PC; Zhang W; Li CY; Lei KF; Yan GQ; Jin SW; Wang JG
    J Proteomics; 2015 Jan; 113():57-72. PubMed ID: 25281561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of fibrinogen to albumin ratio in ankylosing spondylitis: Correlation with disease activity.
    Liu M; Huang Y; Huang Z; Zhong Z; Deng W; Huang Z; Huang Q; Li T
    Clin Chim Acta; 2020 Jun; 505():136-140. PubMed ID: 32112798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMT-based quantitative proteomics analysis and potential serum protein biomarkers for systemic lupus erythematosus.
    Zhou G; Wei P; Lan J; He Q; Guo F; Guo Y; Gu W; Xu T; Liu S
    Clin Chim Acta; 2022 Sep; 534():43-49. PubMed ID: 35810799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitis.
    Skjøt-Arkil H; Schett G; Zhang C; Larsen DV; Wang Y; Zheng Q; Larsen MR; Nawrocki A; Bay-Jensen AC; Henriksen K; Christiansen C; Alexandersen P; Leeming DJ; Karsdal MA
    Clin Exp Rheumatol; 2012; 30(3):371-9. PubMed ID: 22339813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil/lymphocyte and platelet/lymphocyte ratios as potential markers of disease activity in patients with Ankylosing spondylitis: a case-control study.
    Al-Osami MH; Awadh NI; Khalid KB; Awadh AI
    Adv Rheumatol; 2020 Jan; 60(1):13. PubMed ID: 32000859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.
    Di Carlo M; Lato V; Carotti M; Salaffi F
    Health Qual Life Outcomes; 2016 May; 14():78. PubMed ID: 27188166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis].
    Salaffi F; Stancati A; Silvestri A; Carotti M; Grassi W
    Reumatismo; 2005; 57(3):161-73. PubMed ID: 16258600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
    Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
    Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
    Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
    J Rheumatol; 1999 Apr; 26(4):980-4. PubMed ID: 10229432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Deoxyribonuclease 1-like 3 is a potential biomarker for diagnosis of ankylosing spondylitis.
    Sun Y; Ouyang B; Xie Q; Wang L; Zhu S; Jia Y
    Clin Chim Acta; 2020 Apr; 503():197-202. PubMed ID: 31794766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.